Aditxt, Inc. Restricted Stock or Unit Expense
Aditxt, Inc. (ADTX) reported Restricted Stock or Unit Expense of $473.31 thousand for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-31.
Financial Statements › Cash Flow › Other Cash Flow Items
us-gaap:RestrictedStockExpense · last filed 2026-03-31
- Aditxt, Inc. restricted stock or unit expense for the quarter ending 2025-12-31 was $0.00.
- Aditxt, Inc. restricted stock or unit expense for the quarter ending 2025-09-30 was $0.00.
- Aditxt, Inc. restricted stock or unit expense for the quarter ending 2025-06-30 was $473.31K.
- Aditxt, Inc. restricted stock or unit expense for the quarter ending 2025-03-31 was $0.00, a 100.00% decline year-over-year.
- Aditxt, Inc. restricted stock or unit expense for fiscal 2025 was $473.31K.
| Period end | Restricted Stock or Unit Expense 3 month | Restricted Stock or Unit Expense 3 month as first filed | Restricted Stock or Unit Expense 6 month | Restricted Stock or Unit Expense 9 month | Restricted Stock or Unit Expense 12 month |
|---|---|---|---|---|---|
| 2025-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | $0.00 derived: sum of 2 quarters · filed 2026-03-31 | $473.31K derived: sum of 3 quarters · filed 2026-03-31 | $473.31K 10-K · filed 2026-03-31 | |
| 2025-09-30 | $0.00 10-Q · filed 2025-11-18 | $473.31K derived: sum of 2 quarters · filed 2025-11-18 | $473.31K 10-Q · filed 2025-11-18 | ||
| 2025-06-30 | $473.31K 10-Q · filed 2025-08-14 | $473.31K 10-Q · filed 2025-08-14 | |||
| 2025-03-31 | $0.00 10-Q · filed 2025-05-15 | ||||
| 2024-03-31 | $59.96K 10-Q · filed 2024-05-20 | ||||
| 2023-09-30 | $589.01K 10-K · filed 2025-03-31 | $59.96K 10-Q · filed 2024-11-18 | $648.98K derived: sum of 2 quarters · filed 2025-03-31 | $179.89K 10-Q · filed 2024-11-18 | |
| 2023-06-30 | $59.96K 10-Q · filed 2024-08-19 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Rafael Holdings, Inc. (RFL) | United States | $0.000B | -0.00 |
| CDT Equity Inc. (CDT) | United States | $0.000B | -0.01 |
| Protagenic Therapeutics, Inc.\new (PTIX) | United States | $0.001B | |
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B |